Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index.
Abstract
A lthough obesity, reduced physical activity, andaging increase susceptibility to type 2 diabetes,many people exposed to these risk factors donot develop the disease. Recent genome-wide association studies have identified a number of genetic variants that explain some of the interindividual variation in diabetes susceptibility (1–5). There is also a growing body of literature suggesting a role for epigenetic factors in the complex interplay between genes and the environ-ment. Nevertheless, our knowledge about the molecular mechanisms linking environmental factors and type 2 diabetes still remains limited. This perspective will pro-vide some insights into epigenetic mechanisms associated with type 2 diabetes. An overview of epigenetic regulation. Although there is no uniform definition of epigenetics, it has been de-scribed as heritable changes in gene function that occur without a change in the nucleotide sequence (6). Epige-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, changes in human epigenome have been associated with processes related to adaptation and evolution (64, 65), and have also been linked to several diseases, such as cancer (66), type 2 diabetes (67), and autoimmune rheumatic disorders, such as systemic lupus erythematosus (SLE) (68).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [67]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, epigenetic mechanisms may also contribute to these patterns because reduced expression parallels increased DNA methylation of both the COX7A1 promoter (136) and NDUFB6 (137, 139).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Reddy, M. A., Villeneuve, L. M., Wang, M., Lanting, L. L., & Natarajan, R. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.175190 · Cited by 83 · cited 3×
“, IL-6 and MCP-1, in parallel with decreased levels of the H3K9me3 methyltransferase Suv39h1 and a histone demethylase, the lysine-specific demethylase 1 (LSD1) (103,104).”
BackgroundRetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“COX7A1, which is part of complex 4 of the respiratory chain and which shows decreased expression in diabetic muscle, is a target of age-related DNA methylation (23,34).”
BackgroundSelf-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“risk of macrovascular complications (106,107).”
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationPersistent epigenetic differences associated with prenatal exposure to famine in humans
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806560105 · Cited by 3,082
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · cited 1×
“New techniques have made it easier to analyze DNA methylation and histone modifications on a genome-wide scale (19,20).”
BackgroundBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“Although there is no uniform definition of epigenetics, it has been described as heritable changes in gene function that occur without a change in the nucleotide sequence (6).”
BackgroundA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Cited by
Items 201–300 of 655
The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes
Gillberg, L., & Ling, C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00043 · Cited by 51
Self-citationEpigenetics and Type 2 Diabetes Risk
Dhawan, S., & Natarajan, R. D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1168-8 · Cited by 52
Li, H., & Li, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1184734 · Cited by 51
“Nevertheless, T2D is a multi-factorial disease that can be influenced by environment, gender, lifestyle, diet, aging, epigenetics, and genetics (Scott et al., 2007; Ling and Groop, 2009; NCD Risk Factor Collaboration, 2016).”
BackgroundEpigenetics and diabetes treatment: an unrealized promise?
Bramswig, N. C., & Kaestner, K. H. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.002 · Cited by 46
Yang, L.-L., Zhang, Q., Wu, Q., Yi, W., Yu, J., Mu, J., Zhang, J., Zeng, W., & Feng, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.044 · Cited by 45
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Pal, S. C., Eslam, M., & Méndez‐Sánchez, N. (2022) · HORMONES · doi:10.1007/s42000-022-00391-w · Cited by 49
Pheiffer, C., Erasmus, R. T., Kengne, A. P., & Matsha, T. E. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.11.021 · Cited by 45
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism
Lund, J., Rustan, A. C., Løvsletten, N. G., Mudry, J. M., Langleite, T. M., Feng, Y. Z., Stensrud, C., Brubak, M. G., Drevon, C. A., Birkeland, K. I., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175441 · Cited by 43
Yang, T., Gao, X., Sandberg, M., Zollbrecht, C., Zhang, X., Hezel, M. P., Liu, M. R., Peleli, M., Lai, E., Harris, R. A., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3570-3 · Cited by 44
Broholm, C., Brandt, C., Schultz, N. S., Nielsen, A. R., Pedersen, B. K., & Scheele, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2011 · Cited by 43
Epigenetics in the Neoliberal “Regime of Truth”: A Biopolitical Perspective on Knowledge Translation
Dupras, C., & Ravitsky, V. (2015) · The Hastings Center Report · doi:10.1002/hast.522 · Cited by 51
Sadeghabadi, Z. A., Nourbakhsh, M., Pasalar, P., Emamgholipour, S., Golestani, A., Larijani, B. A., & Razzaghy‐Azar, M. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.10.004 · Cited by 43
Epigenetic regulation by polyphenols in diabetes and related complications
Ullah, H., Filippis, A. D., Santarcangelo, C., & Daglia, M. (2020) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-200489 · Cited by 47
“…in the pathogenesis of DM such as genetics (PPAR-γ , KCJN11, HNF4A, ENPP1, GCKR, IRS1, PCSK1 and G6PC2), epigenetics (a molecular connection between environmental factors and DM) and environmental factors (including age, sedentary lifestyle, obesity, unhealthy diet and certain medications) [6–8].”
Kim, K., Joyce, B. T., Zheng, Y., Schreiner, P. J., Jacobs, D. R., Catov, J. M., Shikany, J. M., Carnethon, M. R., Greenland, P., Horn, L. V., et al. (2021) · Diabetes · doi:10.2337/db20-1167 · Cited by 43
Epigenetic alterations in patients with type 2 diabetes mellitus
Karachanak-Yankova, S., Dimova, R. B., Nikolova, D. N., Nesheva, D. V., Koprinarova, M., Maslyankov, S., Tafradjiska, R., Andreeva-Gateva, P. A., Velizarova, M., Hammoudeh, Z., et al. (2015) · Balkan Journal of Medical Genetics · doi:10.1515/bjmg-2015-0081 · Cited by 42
Adnan, M., Jeon, B.-B., Chowdhury, M. H. U., Oh, K., Das, T., Chy, M. N. U., & Cho, D. H. (2022) · Life · doi:10.3390/life12020277 · Cited by 43
Interactions Between Diabetes and Anxiety and Depression
Bystritsky, A., Danial, J., & Kronemyer, D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.001 · Cited by 47
Mehta, A., Ravinder, R., Onteru, S. K., & Singh, D. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.002 · Cited by 42
The role of global histone post-translational modifications during mammalian hibernation
Tessier, S. N., Luu, B. E., Smith, J. C., & Storey, K. B. (2017) · Cryobiology · doi:10.1016/j.cryobiol.2017.02.008 · Cited by 41
Yuan, E., Yang, Y., Cheng, L. Z., Deng, X., Chen, S., Zhou, X. H., & Liu, S. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0660-y · Cited by 42
Huang, C.-C., Kuo, C.-Y., Yang, C., Liu, J., Hsu, R., Lee, K.-I., Su, C., Wu, C.-C., Lin, C., Liu, S., et al. (2019) · Toxicology · doi:10.1016/j.tox.2019.152252 · Cited by 42
Exposome and foetoplacental vascular dysfunction in gestational diabetes mellitus
Valero, P., Fuentes, G., Cornejo, M., Vega, S., Grismaldo, A., Pardo, F., García‐Rivas, G., Hillebrands, J., Faas, M. M., Casanello, P. C., et al. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101019 · Cited by 42
Dayeh, T., & Ling, C. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0057 · Cited by 45
“T2D is a complex disease that results from interactions of genetic, epigenetic and non-genetic factors (Ling and Groop 2009).”
BackgroundSelf-citationEpigenetics in Precision Nutrition
Li, X., & Qi, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040533 · Cited by 43
“It has been suggested that DNA methylation changes might be one of the underlying mechanisms [91].”
BackgroundZhang, P., Chu, T., Dedousis, N. L., Mantell, B. S., SIPULA, I. J., Li, L. Q., Bunce, K. D., Shaw, P. A., Katz, L. S., Zhu, J., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.02.001 · Cited by 45
Zhou, L., Wang, W. T., Yang, C. H., Zeng, T., Hu, M., Wang, X., Li, N., Sun, K., Wang, C., Zhou, J., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00686 · Cited by 42
Daneshpajooh, M., Eliasson, L., Bacos, K., & Ling, C. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1201-4 · Cited by 40
Self-citationCosta-Júnior, J. M., Ferreira, S. M., Kurauti, M. A., Bernstein, D. L., Ruano, E. G., Kameswaran, V., Schug, J., Dias, R. D. F., Zoppi, C. C., Boschero, A. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010001 · Cited by 42
Acetylation and insulin resistance: a focus on metabolic and mitogenic cascades of insulin signaling
Emamgholipour, S., Ebrahimi, R., Bahiraee, A., Niazpour, F., & Meshkani, R. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1699498 · Cited by 43
“Indeed, since the process of acetylation needs the presence of acetyl CoA as a result of glucose metabolism, it has been reported that glucose availability may alter the status of histone acetylation that is dependent on the enzyme ATP-citrate lyase, which is responsible for production of acetyl CoA [152].”
BackgroundInfluentialIntrauterine Programming of Diabetes and Adiposity
Tomar, A. S., Tallapragada, D. S. P., Nongmaithem, S. S., Shrestha, S., Yajnik, C. S., & Chandak, G. R. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0175-6 · Cited by 43
Olioso, D., Dauriz, M., Bacchi, E., Negri, C., Santi, L., Bonora, E., & Moghetti, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01820 · Cited by 42
“The effect of environmental factors on metabolic regulation has recently gained molecular rationale by insights brought by epigenetics (6, 7).”
Diabetic Retinopathy and NADPH Oxidase-2: A Sweet Slippery Road
Kowluru, R. A. (2021) · Antioxidants · doi:10.3390/antiox10050783 · Cited by 43
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 39
School-based primary NCD risk reduction: education and public health perspectives
Bay, J. L., Hipkins, R., Siddiqi, K., Huque, R., Dixon, R., Shirley, D., Tairea, K., Yaqona, D., Mason‐Jones, A. J., & Vickers, M. H. (2016) · Health Promotion International · doi:10.1093/heapro/daw096 · Cited by 48
MicroRNA regulated macrophage activation in obesity
Li, C., Qu, L., Farragher, C., Vella, A. T., & Zhou, B. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0011 · Cited by 39
“All of these processes contribute to the development of type 2 diabetes, atherosclerosis, and associated cardiovascular disorders [30,41,49-51].”
BackgroundMason, E., Tronc, G., Nones, K., Matigian, N., Kim, J., Aronow, B. J., Wolfinger, R. D., Wells, C., & Gibson, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014479 · Cited by 36
Tabong, P. T., Bawontuo, V., Dumah, D. N., Kyilleh, J. M., & Yempabe, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198915 · Cited by 40
Moler, E. R. V., Abakir, A., Eleftheriou, M., Johnson, J. S., Krutovsky, K. V., Lewis, L. C., Ruzov, A. S., Whipple, A. V., & Rajora, O. P. (2018) · Population genomics · doi:10.1007/13836_2018_59 · Cited by 40
Wahab, A., Mahmoudi, O., Kim, J., & Chong, K. T. (2020) · Cells · doi:10.3390/cells9081756 · Cited by 37
Effect of Exercise on DNA Methylation and Metabolism in Human Adipose Tissue and Skeletal Muscle
Rönn, T., & Ling, C. (2013) · Epigenomics · doi:10.2217/epi.13.61 · Cited by 40
Self-citationSafi, S. Z., Qvist, R., Yan, G. O. S., & Ismail, I. S. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-29 · Cited by 39
Hao, G., Youssef, N. A., Davis, C. L., & Su, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.063 · Cited by 39
“Several reviews have described the association between childhood adversity and DNA methylation,[9, 10] and the association between DNA methylation and cardiometabolic disease.[11, 12] The present review, however, is primarily focused on the findings from human studies to indicate the role of DNA methylation in the rel…”
BackgroundDay, S. E., Coletta, R. L., Kim, J. Y., Campbell, L. E., Benjamin, T. R., Roust, L. R., Filippis, E. A. D., Dinu, V., Shaibi, G. Q., Mandarino, L. J., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0246-x · Cited by 37
“DNA methylation in the promoter and untranslated regions (5′ and 3′UTR) have been noted to have regulatory effects on transcription [14–16].”
BackgroundRajan, A., Shi, H., & Xue, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-31560-w · Cited by 36
Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids
Zhou, Y., Suo, W., Zhang, X., Yang, Y., Zhao, W., Li, H., & Ni, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114025 · Cited by 36
Xue, Z., Sjögren, H. O., Salford, L. G., & Widegren, B. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.01.006 · Cited by 36
Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Costantino, S., Paneni, F., & Cosentino, F. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/138920101606150407113644 · Cited by 38
Jiang, H., Lun, Y., Wu, X., Xia, Q., Zhang, X., Xin, S., & Zhang, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018747 · Cited by 35
Role of genetic and environmental factors in DNA methylation of lipid metabolism
He, Z., Zhang, R., Jiang, F., Hou, W., & Hu, C. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.11.005 · Cited by 35
Luo, H., Zhou, Y., Li, Y., & Li, Q. (2013) · BMC Genetics · doi:10.1186/1471-2156-14-58 · Cited by 37
“DNA methylation regulates gene transcription mainly through two mechanisms [50,51].”
BackgroundWu, Y., Cui, W., Zhang, D., Wu, W., & Yang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.18167 · Cited by 37
John, A. N., & Jiang, F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.12.002 · Cited by 43
Diabetes Among Refugee Populations: What Newly Arriving Refugees Can Learn From Resettled Cambodians
Wagner, J. A., Berthold, S. M., Buckley, T., Kong, S., Kuoch, T., & Scully, M. F. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0618-1 · Cited by 38
Epigenetic Mechanisms in the Pathogenesis of Diabetic Retinopathy
Zeng, J., & Chen, B. (2014) · Ophthalmologica · doi:10.1159/000357824 · Cited by 37
Pastor‐Belda, M., Bastida, D., Campillo, N., Pérez-Cárceles, M. D., Motas, M., & Viñas, P. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.07.042 · Cited by 34
Role of Epigenetic Mechanisms in the Vascular Complications of Diabetes
Reddy, M. A., & Natarajan, R. D. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_19 · Cited by 37
“Furthermore, environmental factors and nutrients can affect epigenetic states and regulate the expression of genes associated with various diseases including cancer and diabetes (Sharma et al. 2010; Liu et al. 2008; Ling and Groop 2009).”
BackgroundBridging epigenomics and complex disease: the basics
Teperino, R., Lempradl, A. M., & Pospisilik, J. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1299-z · Cited by 37
Epigenetics: spotlight on type 2 diabetes and obesity
Desiderio, A., Spinelli, R., Ciccarelli, M., Nigro, C., Miele, C., Bèguinot, F., & Raciti, G. A. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0473-1 · Cited by 38
Bricambert, J., Favre, D., Brajkovic, S., Bonnefond, A., Boutry, R., Salvi, R., Plaisance, V., Chikri, M., Chinetti, G., Staels, B., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.09.011 · Cited by 33
Understanding Personalized Training Responses: Can Genetic Assessment Help?
Pickering, C., & Kiely, J. (2017) · The Open Sports Sciences Journal · doi:10.2174/1875399x01710010191 · Cited by 37
“Epigenetics refers to changes in gene function that occur without a change in the nucleotide sequence [162].”
BackgroundPlant gene expression control using genome- and epigenome-editing technologies
Miglani, G. S., Kaur, A., & Kaur, L. (2019) · Journal of Crop Improvement · doi:10.1080/15427528.2019.1678541 · Cited by 33
“The proteins used for this purpose are called methyl-CG-binding proteins (MBPs), such as MeCP2, which can further make use of histone deacetyltransferases (HDACs) and corepressors (Ling and Groop 2009).”
BackgroundThe inflammatory effect of epigenetic factors and modifications in type 2 diabetes
Akbari, M., & Hassan‐Zadeh, V. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00663-9 · Cited by 35
“2015; Ling and Groop 2009).”
BackgroundOlaniyi, K. S., Amusa, O. A., Areola, E. D., & Olatunji, L. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220913847 · Cited by 33
“Therefore, an individual’s susceptibility to the development of T2DM is suggested to rely on the activation of intracellular signaling pathways by environmental factors leading to epigenetic modifications that culminate in changes in gene expression.(11) Epigenetics has to do with altered gene function without any cha…”
BackgroundMetabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers
Kushwaha, K., Sharma, S., & Gupta, J. (2020) · Biochimie · doi:10.1016/j.biochi.2020.01.007 · Cited by 36
The many lives of Myc in the pancreatic β-cell
Rosselot, C., Baumel-Alterzon, S., Li, Y., Brill, G., Lambertini, L., Katz, L. S., Lu, G., García-Ocaña, A., & Scott, D. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011149 · Cited by 37
Liu, C., Li, W., Chen, X., Liu, M., Zuo, L., Chen, L., Chen, H., Xu, W., & Hao, G. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3595 · Cited by 33
Colsoul, B., Jacobs, G., Philippaert, K., Owsianik, G., Segal, A., Nilius, B., Voets, T., Schuit, F. C., & Vennekens, R. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1389-7 · Cited by 32
“This can have an effect on the susceptibility to disruptions in glucose homeostasis and metabolic regulation and on the risk profile for diabetes type 2 [9, 19, 35].”
Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis
Chen, J., Zhang, Z., Wang, N., Guo, M., Chi, X., Pan, Y., Jiang, J., Niu, J., Ksimu, S., Li, J. Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06328-3 · Cited by 36
Regulation of PTEN/AKT/FAK pathways by PPARγ impacts on fibrosis in diabetic nephropathy
Yan, R., Wang, Y., Shi, M., Xiao, Y., Liu, L., Liu, L., & Guo, B. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27937 · Cited by 31
Monitoring the ‘diabetes epidemic’: A framing analysis of United Kingdom print news 1993-2013
Foley, K. M., McNaughton, D. A., & Ward, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225794 · Cited by 33
Sharma, N., Comeau, M. E., Montoya, D. J., Pellegrini, M. A., Howard, T. D., Langefeld, C. D., & Das, S. K. (2020) · Diabetes · doi:10.2337/db20-0117 · Cited by 38
Abbas, Z., Tayara, H., & Chong, K. T. (2021) · Genes · doi:10.3390/genes12020296 · Cited by 31
Yuan, Q., Chen, L., Liu, C., Xu, K., Mao, X., & Liu, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025167 · Cited by 33
To be or not to be: the regulation of mRNA fate as a survival strategy during mammalian hibernation
Tessier, S. N., & Storey, K. B. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0512-9 · Cited by 31
“corepressors and posttranslational modifications of histone tails alter chromatin structure and accessibility, collectively affecting transcriptional competence (Ling and Groop 2009).”
Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications
Naseri, R., Navabi, S. J., Samimi, Z., Mishra, A. P., Nigam, M., Chandra, H., Olatunde, A., Tijjani, H., Morais‐Urano, R. P., & Farzaei, M. H. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00327-y · Cited by 32
“On the contrary in T2DM, prolonged dyslipidemia, hyperglycemia and increased oxidative stress that results in altered homeostasis could lead to epigenetic changes [97] .”
BackgroundPotential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood
Day, S. E., Coletta, R. L., Kim, J. Y., Garcia, L. A., Campbell, L. E., Benjamin, T. R., Roust, L. R., Filippis, E. A. D., Mandarino, L. J., & Coletta, D. K. (2017) · Epigenetics · doi:10.1080/15592294.2017.1281501 · Cited by 31
“Epigenetic mechanisms have become important for determining the molecular basis of diseases, because they are due to both genetic and environmental factors.(16) The influence of these factors on DNA methylation has also made it a promising biomarker for disease.”
BackgroundCuthbert, C. E., Foster, J. E., & Ramdath, D. D. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002501 · Cited by 38
Zaiou, M., Amrani, R., Rihn, B. H., & Hajri, T. (2021) · Biomedicines · doi:10.3390/biomedicines9091256 · Cited by 30
Epigenetics: key to improve delayed wound healing in type 2 diabetes
Dubey, R., Prabhakar, P. K., & Gupta, J. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04285-0 · Cited by 32
Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity
Rautenberg, E. K., Hamzaoui, Y., & Coletta, D. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968268 · Cited by 33
“There are several outstanding reviews on this topic, and we recommend the following to the readers (73, 74).”
BackgroundNew insights from monogenic diabetes for “common” type 2 diabetes
Tallapragada, D. S. P., Bhaskar, S., & Chandak, G. R. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00251 · Cited by 35
“…histone modifications, non-coding RNAs, microRNAs are plausible means by which environmental factors integrate their effects with Frontiers in Genetics | www.frontiersin.org 9 August 2015 | Volume 6 | Article 251 genetic variants to mediate T2D risk (Ling and Groop, 2009; Waki et al., 2012).”
BackgroundRole of site-specific DNA demethylation in TNFα-induced MMP9 expression in keratinocytes
Li, L., Ren, M., Yang, C. H., Lao, G., Chen, L., Luo, H., Feng, Z., & Li, Y. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0172 · Cited by 30
Pradhan, P., Upadhyay, N., Tiwari, A., & Singh, L. P. (2016) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000145 · Cited by 32
Heyman‐Lindén, L., Seki, Y., Storm, P., Jones, H. A., Charron, M. J., Berger, K., & Holm, C. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.022 · Cited by 29
“A growing body of literature suggests that aberrant DNA methylation mayplayaroleindiseasessuchasNAFLDandT2DM[83 – 85],although the understanding of these mechanisms remains limited.”
Abdullah, N., Murad, N. A. A., Attia, J. R., Oldmeadow, C. J., Kamaruddin, M. A., Jalal, N. A., Ismail, N., Jamal, R. A., Scott, R. J., & Holliday, E. G. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15122813 · Cited by 32
Wu, H., Yang, A., Lau, E. S. H., Zhang, X., Fan, B., Shi, M., Huang, C., Ronald, C. W., Kong, A. P. S., Chow, E., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004261 · Cited by 31
Living long and ageing well: is epigenomics the missing link between nature and nurture?
The ACUME2 Project, Rea, I. M., Dellett, M., & Mills, K. (2015) · Biogerontology · doi:10.1007/s10522-015-9589-5 · Cited by 32
“…NDUFB6 expression, and the group later reported that COX71A, central to the oxidative phosphorylation (OXPHOS) in the mitochondrial energy pathway, also showed increased methylation in the COX7A1 promoter in muscle from elderly, compared with young twins (Ling and Groop 2009; Rönn et al. 2008).”
BackgroundEx vivo detection of histone H1 modified with advanced glycation end products
Pashikanti, S., Boissonneault, G. A., & Cervantes-Laurean, D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.034 · Cited by 29
Genetics and epigenetics purpose in nonalcoholic fatty liver disease
Botello-Manilla, A. E., Chávez-Tapia, N. C., Uribe, M., & Nuño‐Lámbarri, N. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1780915 · Cited by 33
Developmental origins of diabetes mellitus: Environmental epigenomics and emerging patterns
Zhu, H., Ding, G., Liu, X., & Huang, H. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13403 · Cited by 28
“Previous research usually examined the diabetes susceptibility based on a combined effect of lifestyle and genetics.(2,3) One important risk factor is metabolic imbalance, with excess of calorie intake and low energy expenditure.”
BackgroundEze, I. C., Imboden, M., Kumar, A., Adam, M., von Eckardstein, A., Stolz, D., Gerbase, M. W., Künzli, N., Turk, A. J., Schindler, C., et al. (2016) · Environmental Health · doi:10.1186/s12940-016-0120-5 · Cited by 29
Deficiency of IRTKS as an adaptor of insulin receptor leads to insulin resistance
Huang, L., Wang, Y., Wei, B., Yang, J., Wang, J., Wu, B., Zhang, Z.-Z., Hou, Y., Sun, W., Hu, R., et al. (2013) · Cell Research · doi:10.1038/cr.2013.99 · Cited by 28
Epigenetics and type II diabetes mellitus: underlying mechanisms of prenatal predisposition
Sterns, J. D., Smith, C. B., Steele, J. R., Stevenson, K. L., & Gallicano, G. I. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00015 · Cited by 30
Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine
Kowluru, R. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093019 · Cited by 27
Harvey, K. M., Cooke, R. F., & Moriel, P. (2021) · Frontiers in Animal Science · doi:10.3389/fanim.2021.730356 · Cited by 32
Utilising the precision nutrition toolkit in the path towards precision medicine
Sawicki, C. M., Haslam, D. E., & Bhupathiraju, S. N. (2023) · Proceedings of The Nutrition Society · doi:10.1017/s0029665123003038 · Cited by 29
Maternal undernutrition and cardiometabolic disease: a latin american perspective
López-Jaramillo, P. A., Gómez-Arbeláez, D., Sotomayor-Rubio, A., Mantilla-Garcia, D., & López-López, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0293-8 · Cited by 31
“Epigenetic mechanisms include DNA methylations, histone modifications, and microRNAs [43], and can help to explain how individuals with identical or similar DNA, when exposed to different environmental signals, express diverse phenotypes and differ in their susceptibility to certain pathologies.”
BackgroundTherapeutic prospects for epigenetic modulation
Heightman, T. D. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561786 · Cited by 28
“In patients with type II diabetes, DNA methylation of the PPARGC1A promoter is elevated in pancreatic islets compared with those of healthy control subjects, resulting in reduced PPARg receptor expression, which in turn correlates with reduced glucose-stimulated insulin secretion in islets [69].”
BackgroundCofactors As Metabolic Sensors Driving Cell Adaptation in Physiology and Disease
Rabhi, N., Hannou, S. A., Froguel, P., & Annicotte, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00304 · Cited by 27
Xi, Z., Fang, L., Xu, J., Li, B., Zuo, Z., Lv, L., & Wang, C. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.03.101 · Cited by 26
Metadata
- Authors
- Ling, C., & Groop, L.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-12-01
- Volume
- 58
- Issue
- 12
- Pages
- 2718-2725
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2780862
- OpenAlex
- W2164575981
- Cited by
- 617
- References
- 117
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 20 · 2023: 35 · 2022: 24 · 2021: 35 · 2020: 39 · 2019: 50 · 2018: 49 · 2017: 56 · 2016: 44 · 2015: 58 · 2014: 41 · 2013: 49 · 2012: 36
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Eli Lilly and Company
- Lunds Universitet
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- epigenetics, type 2 diabetes, environmental risk factors, gene-environment interaction, obesity, physical inactivity, aging, genetic susceptibility, epigenetic regulation
- MeSH terms
- Aging, Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Food, Histones, Humans, Infant, Newborn, Obesity, Risk Factors, Transcription, Genetic, Exercise, DNA Methylation, MicroRNAs, Epigenesis, Genetic, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.